NO20065231L - Nye imidazoler - Google Patents
Nye imidazolerInfo
- Publication number
- NO20065231L NO20065231L NO20065231A NO20065231A NO20065231L NO 20065231 L NO20065231 L NO 20065231L NO 20065231 A NO20065231 A NO 20065231A NO 20065231 A NO20065231 A NO 20065231A NO 20065231 L NO20065231 L NO 20065231L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- new imidazoles
- new
- methods
- imidazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Nye imidazolforbindelser tilveiebrakt. Forbindelsene er anvendelige som HMGCo-A-reduktaseinhibitorer. Også tilveiebrakt er farmasøytiske sammensetninger av forbindelsene. Fremgangsmåter for fremstilling og fremgangsmåter for anvendelse av forbindelsene er også tilveiebrakt.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56312404P | 2004-04-16 | 2004-04-16 | |
US60070504P | 2004-08-11 | 2004-08-11 | |
PCT/US2005/012255 WO2005105079A2 (en) | 2004-04-16 | 2005-04-12 | Novel imidazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065231L true NO20065231L (no) | 2007-01-09 |
Family
ID=35242215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065231A NO20065231L (no) | 2004-04-16 | 2006-11-14 | Nye imidazoler |
Country Status (23)
Country | Link |
---|---|
US (2) | US20050239857A1 (no) |
EP (1) | EP1740549A2 (no) |
JP (1) | JP2007532653A (no) |
KR (1) | KR20060133013A (no) |
AP (1) | AP2006003766A0 (no) |
AR (1) | AR049023A1 (no) |
AU (1) | AU2005237428A1 (no) |
BR (1) | BRPI0509926A (no) |
CA (1) | CA2563222A1 (no) |
CR (1) | CR8687A (no) |
EA (1) | EA200601678A1 (no) |
EC (1) | ECSP066931A (no) |
IL (1) | IL178208A0 (no) |
MA (1) | MA28539B1 (no) |
MX (1) | MXPA06011657A (no) |
NO (1) | NO20065231L (no) |
NZ (1) | NZ550061A (no) |
PA (1) | PA8630801A1 (no) |
PE (1) | PE20060184A1 (no) |
SV (1) | SV2006002089A (no) |
TW (1) | TW200538442A (no) |
UY (1) | UY28856A1 (no) |
WO (1) | WO2005105079A2 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2328384T3 (es) * | 2004-11-23 | 2009-11-12 | Warner-Lambert Company Llc | Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia. |
WO2007042910A1 (en) * | 2005-10-14 | 2007-04-19 | Pfizer Products Inc. | Imidazoles and their use as hmg-coa reductase inhibitors |
EP1948168A4 (en) * | 2005-10-28 | 2010-10-06 | Numerate Inc | COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND / OR HMG-COA REDUCTASE |
WO2007049121A1 (en) * | 2005-10-28 | 2007-05-03 | Pfizer Products Inc. | Crystal form of sodium; (3r,5r)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxy-heptanoate |
WO2007107843A1 (en) * | 2006-03-22 | 2007-09-27 | Pfizer Products Inc. | Methods of treatment with cetp inhibitors |
WO2008038098A1 (en) * | 2006-09-25 | 2008-04-03 | Pfizer Products Inc. | Crystalline form of 7 [5-cyclopropyl)-4-o-fluorobenzylcarbamoyl)-2-(4-fluorophenyl)-imidazol-1-yl]-3r,5r-dihydroxyheptanoic |
DE102007051339A1 (de) * | 2007-10-26 | 2009-04-30 | Müller-Enoch, Dieter, Prof. Dr. | Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien |
DE102010012232A1 (de) | 2010-03-19 | 2011-09-22 | Acrovis Biostructures Gmbh | Irnidazole |
DE102010012235A1 (de) | 2010-03-19 | 2011-09-22 | Acrovis Biostructures Gmbh | Imidazole |
DE102010012233A1 (de) | 2010-03-19 | 2011-09-22 | Acrovis Biostructures Gmbh | Imidazole |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4755606A (en) * | 1985-05-22 | 1988-07-05 | Sandoz Pharm. Corp. | Imidazolyl-3,5-di-(diphenyl-butylsilyloxy) carboxylic acid ester intermediates |
US4808607A (en) * | 1985-05-22 | 1989-02-28 | Sandoz Pharm. Corp. | Imidazole analogs of mevalonolactone and derivatives thereof for use in inhibiting cholesterol biosynthesis and lowering blood cholesterol level |
US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
NL8902441A (nl) * | 1988-10-03 | 1990-05-01 | Glaxo Group Ltd | Chemische verbinding. |
FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
US5252322A (en) * | 1989-09-22 | 1993-10-12 | The Gillette Company | Skin tanning compositions containing imidazoles |
BR9609872A (pt) * | 1995-07-17 | 1999-03-23 | Warner Lambert Co | Hemi sal de cálcio de ácido (R-(R*R*)]-2-(4-fluorfenil-)-beta delta-diidróxi-5-(1-metiletil)-3-fenil-4- [(fenilamino) carbonil]-1H- pirrol-1heptanóico (atorvasta-tina)c ristalino |
US5705145A (en) * | 1996-08-21 | 1998-01-06 | E-L Management Corp. | Skin tanning compositions and method |
DE60029803T2 (de) * | 1999-09-20 | 2007-09-20 | Nippon Soda Co. Ltd. | Verfahren für die herstellung von 4(5)-amino-5(4)-carboxamidoimidazolen und deren zwischenprodukte |
-
2005
- 2005-04-12 CA CA002563222A patent/CA2563222A1/en not_active Abandoned
- 2005-04-12 BR BRPI0509926-9A patent/BRPI0509926A/pt not_active IP Right Cessation
- 2005-04-12 NZ NZ550061A patent/NZ550061A/en unknown
- 2005-04-12 JP JP2007508439A patent/JP2007532653A/ja not_active Ceased
- 2005-04-12 EP EP05733869A patent/EP1740549A2/en not_active Withdrawn
- 2005-04-12 AU AU2005237428A patent/AU2005237428A1/en not_active Abandoned
- 2005-04-12 EA EA200601678A patent/EA200601678A1/ru unknown
- 2005-04-12 WO PCT/US2005/012255 patent/WO2005105079A2/en active Search and Examination
- 2005-04-12 MX MXPA06011657A patent/MXPA06011657A/es not_active Application Discontinuation
- 2005-04-12 AP AP2006003766A patent/AP2006003766A0/xx unknown
- 2005-04-12 KR KR1020067021283A patent/KR20060133013A/ko not_active Application Discontinuation
- 2005-04-13 TW TW094111697A patent/TW200538442A/zh unknown
- 2005-04-13 US US11/105,288 patent/US20050239857A1/en not_active Abandoned
- 2005-04-15 PE PE2005000420A patent/PE20060184A1/es not_active Application Discontinuation
- 2005-04-15 AR ARP050101510A patent/AR049023A1/es unknown
- 2005-04-15 SV SV2005002089A patent/SV2006002089A/es not_active Application Discontinuation
- 2005-04-15 UY UY28856A patent/UY28856A1/es not_active Application Discontinuation
- 2005-04-15 PA PA20058630801A patent/PA8630801A1/es unknown
-
2006
- 2006-03-24 US US11/389,664 patent/US20060287378A1/en not_active Abandoned
- 2006-09-20 IL IL178208A patent/IL178208A0/en unknown
- 2006-10-12 CR CR8687A patent/CR8687A/es not_active Application Discontinuation
- 2006-10-16 EC EC2006006931A patent/ECSP066931A/es unknown
- 2006-10-16 MA MA29394A patent/MA28539B1/fr unknown
- 2006-11-14 NO NO20065231A patent/NO20065231L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MA28539B1 (fr) | 2007-04-03 |
SV2006002089A (es) | 2006-02-15 |
CA2563222A1 (en) | 2005-11-10 |
NZ550061A (en) | 2009-05-31 |
AR049023A1 (es) | 2006-06-21 |
CR8687A (es) | 2007-06-29 |
WO2005105079A2 (en) | 2005-11-10 |
AU2005237428A1 (en) | 2005-11-10 |
US20060287378A1 (en) | 2006-12-21 |
KR20060133013A (ko) | 2006-12-22 |
PE20060184A1 (es) | 2006-04-22 |
EA200601678A1 (ru) | 2007-04-27 |
ECSP066931A (es) | 2006-12-20 |
JP2007532653A (ja) | 2007-11-15 |
US20050239857A1 (en) | 2005-10-27 |
IL178208A0 (en) | 2006-12-31 |
TW200538442A (en) | 2005-12-01 |
EP1740549A2 (en) | 2007-01-10 |
AP2006003766A0 (en) | 2006-10-31 |
MXPA06011657A (es) | 2007-04-23 |
WO2005105079A3 (en) | 2006-01-12 |
UY28856A1 (es) | 2005-11-30 |
BRPI0509926A (pt) | 2007-09-18 |
PA8630801A1 (es) | 2006-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065231L (no) | Nye imidazoler | |
LTC1934174I2 (lt) | Azetinidai kaip MEK inhibitoriai, skirti proliferacinių ligų gydymui | |
EA201070278A1 (ru) | Ингибиторы гамма-секретазы | |
PH12015501484A1 (en) | Heteroaryl compounds and uses thereof | |
NO20071619L (no) | Fremgangsmate for fremstilling av indazol forbindelse | |
MY149960A (en) | 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases | |
CR20140215A (es) | Ciclopenta (d) pirimidinas como inhibidores de la proteina cinasa akt | |
EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
NO20092658L (no) | New compounds | |
MX2009011211A (es) | Indoles sustituidos en la posicion 7 inhibidores de mci-1. | |
ATE362932T1 (de) | Azaindolverbindungen als kinaseinhibitoren | |
EA200970156A1 (ru) | Пиридизиноновые производные | |
ATE479687T1 (de) | Kinaseinhibitoren | |
PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
AU2009236256A8 (en) | Small molecule inhibitors of the pleckstrin homology domain and methods for using same | |
EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
GEP20156242B (en) | 2-arylimidazole derivatives as pde10a enzyme inhibitors | |
TN2011000207A1 (en) | Akt and p70 s6 kinase inhibitors | |
GEP20156241B (en) | Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors | |
NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
EA201071224A1 (ru) | Ингибиторы limk2, композиции, содержащие их, и способы их применения | |
UA99787C2 (en) | Lactams as beta secretase inhibitors | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
UY30801A1 (es) | Compuestos calciliticos | |
NO20080839L (no) | Isotopsubstituerte protonpumpeinhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |